In this study, The RETeval device was be used as a tool to track the trauma level associated with anti-VEGF injections in both the infected eye and the non-injected eye. This study also highlights the capability of our device to help the physician check if the real effect of injections during a 1-month period of time as Previous work has shown on the month time scale an improved flicker implicit time indicating the anti-VEGF injections improve retinal function at this longer time scale.